Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
90 people get RVXCF.PK articles and Market Currents by email alert.
Get email alerts on RVXCF.PK »
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
To learn more about Seeking Alpha Pro, click here.
There are no Transcripts on RVXCF.PK.
There are no News articles on RVXCF.PK.
RVXCF.PK vs. ETF Alternatives
Company Description
Currently, there's no company description for RVXCF.PK.
- All
- | Earnings
- | Dividends
- | M&A
- | On the move
- Saturday, March 6, 2010, 1:35 PM Pfizer (PFE) sunk $2B+ into R&D for a new cholesterol drug, but was unsuccessful. Now meet Resverlogix (RVXCF.PK), the Canadian firm being courted by Big Pharma because it may succeed where Pfizer failed. Shares rose 38% yesterday, and have more than doubled this year. Comment!
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.